Top 20 of Thrombosis

Article title # Publications/# Citations

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

2002: Writing Group for the Women's Health Initiative Investigators; GLAnderson; SABeresford; BVHoward; RDJackson; KCJohnson; CKooperberg; JMKotchen; ... AZLaCroix; JOckene; RLPrentice; JERossouw; MLStefanick;


Atherosclerosis. the road ahead.

2001: CKGlass; JLWitztum;


The immune response in atherosclerosis: a double-edged sword.

2006: GKHansson; PLibby;


Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

2005: Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators; JABaron; JABolognese; RSBresalier; KHorgan; MAKonstam; ALanas; CLines; ... DMorton; BOxenius; HQuan; RRiddell; RSSandler;


Endothelial cells in physiology and in the pathophysiology of vascular disorders.

1998: ESBarnathan; CABuck; DBCines; BAHug; BAKonkle; JLoscalzo; KRMcCrae; RPMcEver; ... JSPober; ESPollak; AMSchmidt; BSSchwartz; DMStern; TMWick; GAZimmerman;


Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

2006: National Surgical Adjuvant Breast and Bowel Project (NSABP); JNAtkins; TBBevers; RSCecchini; JPCostantino; WMCronin; LFehrenbacher; LGFord; ... PAGanz; JJames; VCJordan; SMLippman; RGMargolese; WMcCaskill-Stevens; ERPajon; SEReis; ARobidoux; CDRunowicz; VGVogel; JLWade; DLWickerham; NWolmark;


Prasugrel versus clopidogrel in patients with acute coronary syndromes.

2007: TRITON-TIMI 38 Investigators; EMAntman; DArdissino; EBraunwald; SDe Servi; CMGibson; SGottlieb; CHMcCabe; ... GMontalescot; SAMurphy; FJNeumann; JRiesmeyer; WRuzyllo; GWeerakkody; SDWiviott;


Integrins and other cell adhesion molecules.

1990: SMAlbelda; CABuck;


Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

2003: SIRIUS Investigators; RPCaputo; PJFitzgerald; DRHolmes; JLJaeger; DJKereiakes; REKuntz; MBLeon; ... JWMoses; CO'Shaughnessy; JJPopma; PSTeirstein; DOWilliams;


Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

2002: ZSGalis; JJKhatri;


Fibronectins: multifunctional modular glycoproteins.

1982: ROHynes; KMYamada;


VEGF inhibition and renal thrombotic microangiopathy.

2008: CEAlpers; PHBackx; LBarisoni; VEremina; NFerrara; HPGerber; MHaas; HHochster; ... JAJefferson; MGKabir; JBKopp; JKowalewska; SEQuaggin; CRichardson; JWeisstuch;


A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

1995: ABChandler; REDinsmore; VFuster; SGlagov; WInsull; MERosenfeld; CJSchwartz; HCStary; WDWagner; RWWissler;


CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.

1998: IAnagnostopoulos; RFörster; MGräfe; VHenn; RAKroczek; GMüller-Berghaus; JRSlupsky;


Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

1989: TADrake; TSEdgington; JHMorrissey;


The hazards of scoring the quality of clinical trials for meta-analysis.

1999: RBloch; MEgger; PJüni; AWitschi;


Protease-activated receptors in hemostasis, thrombosis and vascular biology.

2005: SRCoughlin;


Cytochrome p-450 polymorphisms and response to clopidogrel.

2008: EMAntman; JTBrandt; EBraunwald; SLClose; RDHockett; WMacias; JLMega; MSSabatine; ... LShen; JRWalker; SDWiviott;


Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

2002: CREDO Investigators. Clopidogrel for the Reduction of Events During Observation; PBBerger; ADeLago; ETFry; JTMann; SRSteinhubl; EJTopol; CWilmer;


Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

2005: FAiroldi; EBonizzoni; CBriguori; MCarlino; AChieffo; AColombo; NCorvaja; LGe; ... UGerckens; EGrube; IIakovou; IMichev; MMontorfano; GMSangiorgi; TSchmidt; GStanković;